Cabaletta Bio, Inc. (NASDAQ:CABA) Receives $20.33 Average Target Price from Brokerages
Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have earned an average recommendation of “Buy” from the ten ratings firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating […]
Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have earned an average recommendation of “Buy” from the ten ratings firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating […]
